Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Viatris’ Malik to retire in April

Plus: New CFO for NewAmsterdam and more from Persephone, Eledon and Attgeno

By Richard Guy, Biopharma Analyst
October 24, 2023 12:09 AM UTC

Rajiv Malik is retiring as president of  Viatris Inc. (NASDAQ:VTRS), effective April 1, 2024. Malik, who became president of Viatris in November 2020, will remain on the company’s board. The company did not name a successor. 

Cardiovascular disease company NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) hired Ian Somaiya as CFO. Somaiya, a former biotechnology research analyst, was CFO of Elucida Oncology Inc...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Attgeno AB

Eledon Pharmaceuticals Inc.

Newamsterdam Pharma Co. N.V.

Persephone Biosciences Inc.

Viatris Inc.